Human in vitro induced T regulatory cells and memory T cells share common demethylation of specific FOXP3 promoter region

Clinical and Translational Allergy

Kari C. Nadeau³  Rosa Baccheta¹  Laura Passerini¹  Rebecca N. Bauer³  Sven Olek⁴  Udo Baron⁴  Janika Schulze⁴  Philippe Bégin² 

[1] San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;Division of Allergy, Department of Pediatrics, CHU Sainte-Justine, Montreal, Canada;Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Stanford University, Stanford, CA, USA;Epiontis, Berlin, Germany

关键词: Induced;    IPDR;    Assay;    Promoter;    Methylation;    FOXP3;    TSDR;    Epigenetic;    Treg;   

Others  :  1231128
DOI  :  10.1186/s13601-015-0079-2

 received in 2015-04-15, accepted in 2015-08-18,  发布年份 2015

【 摘 要 】

Background

The FOXP3 gene is the master regulator for T regulatory cells and is under tight DNA methylation control at the Treg specific demethylated region (TSDR) in its first intron. This said, methylation of its promoter region, the significance of which is unknown, has also been associated with various immune-related disease states such as asthma, food allergy, auto-immunity and cancer. Here, we used induced T regulatory cells (iTreg) as a target cell population to identify candidate hypomethylated CpG sites in the FOXP3 gene promoter to design a DNA methylation quantitative assay for this region.

Findings

Three CpG sites at the promoter region showed clear demethylation pattern associated with high FOXP3 expression after activation in presence of TGFβ and were selected as primary targets to design methylation-dependent RT-PCR primers and probes. We then examined the methylation of this ‘inducible-promoter-demethylated-region’ (IPDR) in various FOXP3+ T cell subsets. Both naïve and memory thymic-derived Treg cells were found to be fully demethylated at both the IPDR and TSDR. Interestingly, in addition to iTregs, both CD25− and CD25 ^loconventional memory CD4+CD45RA− T cells displayed a high fraction of IPDR demethylated cells in absence of TSDR demethylation.

Conclusion

This implies that the fraction of memory T cells should be taken in account when interpreting FOXP3 promoter methylation results from clinical studies. This approach, which is available for testing in clinical samples could have diagnostic and prognostic value in patients with immune or auto-inflammatory diseases.

【 授权许可】

   
2015 Bégin et al.

【 图 表 】

Fig.1.

Fig.2.

【 参考文献 】

• [1]Ohkura N, Kitagawa Y, Sakaguchi S: Development and maintenance of regulatory T cells. Immunity 2013, 38(3):414-423.
• [2]Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J, et al.: DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007, 37(9):2378-2389.
• [3]Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, Liebenberg V, et al.: Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009, 69(2):599-608.
• [4]Hew KM, Walker AI, Kohli A, Garcia M, Syed A, McDonald-Hyman C, et al.: Childhood exposure to ambient polycyclic aromatic hydrocarbons is linked to epigenetic modifications and impaired systemic immunity in T cells. Clin Exp Allergy. 2015, 45(1):238-248.
• [5]Syed A, Garcia MA, Lyu SC, Bucayu R, Kohli A, Ishida S, et al.: Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol 2014, 133(2):500-510.
• [6]Wang YY, Wang Q, Sun XH, Liu RZ, Shu Y, Kanekura T, et al.: DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis. Br J Dermatol 2014, 171(1):39-47.
• [7]Kennedy A, Schmidt EM, Cribbs AP, Penn H, Amjadi P, Syed K, et al.: A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cells. Eur J Immunol. 2014, 44(10):2968-2978.
• [8]Schultze FC, Andag R, Alwahsh SM, Toncheva D, Maslyankov S, Yaramov N, et al.: FoxP3 demethylation is increased in human colorectal cancer and rat cholangiocarcinoma tissue. Clin Biochem 2014, 47(3):201-205.
• [9]Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S, et al.: Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 2013, 14(4):307-308.
• [10]McMurchy AN, Gillies J, Gizzi MC, Riba M, Garcia-Manteiga JM, Cittaro D, et al.: A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells. Blood 2013, 121(8):1265-1275.
• [11]Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY: Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 2012, 150(1):29-38.
• [12]Bilate AM, Lafaille JJ: Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu Rev Immunol 2012, 30:733-758.
• [13]Wang J, Huizinga TW, Toes RE: De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid. J Immunol. 2009, 183(6):4119-4126.
• [14]Sehouli J, Loddenkemper C, Cornu T, Schwachula T, Hoffmuller U, Grutzkau A, et al.: Epigenetic quantification of tumor-infiltrating T-lymphocytes. Epigenetics. 2011, 6(2):236-246.
• [15]Lu L, Ma J, Li Z, Lan Q, Chen M, Liu Y, et al.: All-trans retinoic acid promotes TGF-beta-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus. PLoS One 2011, 6(9):e24590.
• [16]Laurence A, Belkaid Y, O’Shea JJ: A degrading view of regulatory T cells. Immunity 2013, 39(2):201-203.